Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 0
- Grants since 2016
- 2 323
Grants received
2026 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2026 · grant · Academic Research
AYA LASSO: A statewide platform to assess and improve long-term health outcomes in AYA cancer survivors
Michael Roth · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2026 · grant · Academic Research
A CRISPR-guided, Cancer Cell-specific Killing System
Lawrence Kwong · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2026 · grant · Academic Research
I-PROTECT - Intratumoral Prevention and Risk Outcomes in Targeted Early Cancer Treatment with Immunotherapy
Moran Amit · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2026–2028 · award
GEM Study (Genética y Epidemiología del Myeloma Study): Investigating diversity in myeloma risk, clinical attributes, and outcomes
Michelle Hildebrandt · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2026–2028 · award
Adaptive Emotional Support in Expressive Writing for Chinese Cancer Survivors
Yusi (Aveva) Xu · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2026 · grant · Academic Research
Intergenerational effects of paternal obesity on lung immune dysregulation and tumorigenesis
Andrea Viale · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2026 · grant · Academic Research
The Future of Cancer Research: Training Program for Basic and Translational Scientists
Khandan Keyomarsi · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2026–2031 · award
Targeting Early Events in Kidney Cancer - Integrating metabolism and immune surveillance for prevention
Luigi Perelli · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2026–2029 · award
Accelerating In Vivo TCR Therapy for Uveal Melanoma Targeting SLC45A2
Cassian Yee · The University of Texas MD Anderson Cancer Center · funded by Melanoma Research Alliance
2026 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2026–2028 · award
Study of VHL tumor suppressor in medulloblastoma
Ashutosh Singh · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2026 · research · Research
Beyond Per-Protocol Effects: Improving Study Designs To Maximize Patient Choice
Kerollos Wanis · The University of Texas MD Anderson Cancer Center · funded by Patient-Centered Outcomes Research Institute
2026–2028 · award
Investigating mechanisms of trastuzumab resistance in pan-cancer PDXs
Funda Meric-Bernstam · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2026 · grant · CPRIT Scholar
Recruitment of Established Investigators
The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2026 · grant · Academic Research
Generation of TROP2-Selective Cyclic Peptide Drug Conjugates
Niki Zacharias Millward · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2026–2027 · award
Application of an Image-Based Risk Assessment Model To High-Risk Women
Abenaa Brewster · The University of Texas MD Anderson Cancer Center · funded by Breast Cancer Research Foundation
2026–2027 · award
Dual GLP-1/GIP Receptor Agonism for Mitigation of Aromatase Inhibitor-Induced Toxicities: A Pilot Biomarker Study
Sharon Giordano · The University of Texas MD Anderson Cancer Center · funded by Breast Cancer Research Foundation
2026–2028 · award
Cancer Care Delivery and Breast Cancer: Impact and Associated Factors
Mariana Chavez Mac Gregor · The University of Texas MD Anderson Cancer Center · funded by Breast Cancer Research Foundation
2026 · facilities
Structure determination for Macromolecular proteins and protein complexes
Paul Leonard · The University of Texas MD Anderson Cancer Center · funded by U.S. Department of Energy
2026 · research
Developing a dual-targeting antibody-based therapy for HER2-positive metastatic breast cancer
Ansel Nalin · The University of Texas MD Anderson Cancer Center · funded by Breast Cancer Research Foundation
2026 · research
Testing low-dose radiation as a targeted treatment for side effects caused by immunotherapy
Chidinma Anakwenze · The University of Texas MD Anderson Cancer Center · funded by Breast Cancer Research Foundation
2026 · career development · Young Investigator Award
A novel dual action approach to combat urinary tract infection and bladder cancer
Emanuele Crupi · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · career development · Young Investigator Award
Clinical Natural History and Spatial Transcriptomics of Adenoid Cystic Carcinoma Across Typical and Atypical Primary Sites
Felippe Lazar Neto · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · career development · Young Investigator Award
Novel dual action anti-CD74 therapy to mitigate immune checkpoint induced pneumonitis (ICT-P) and augment antitumor efficacy.
Tony Zhuang · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · training · HIP Fellow Award
HIP Fellow Award 2026: Daisy Diaz Rohena
Daisy Diaz Rohena · The University of Texas MD Anderson Cancer Center · funded by American Society of Hematology
2026 · career development · Young Investigator Award
Preclinical development of a novel anti-CXCR5 nanobody-CAR T-cell therapy for Tfh-derived T-cell lymphomas
Karan Chohan · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · career development · Young Investigator Award
A Bispecific HER2-CD47 Antibody-Drug Conjugate to Sensitize Breast Cancer to Immunotherapy
Ansel Nalin · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · research · Advanced Clinical Research Award
Circulating Tumor Material-Guided Local and Ablative Radiotherapy for Oligometastatic Breast Cancer (CLARITy Trial): A Phase II Prospective Randomized Clinical Trial
Chelain Goodman · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · career development · Young Investigator Award
Signaling and Inflammatory Signatures Underlying Resistance and Response to Momelotinib Plus Gilteritinib in FLT3 mutated AML
Leticia Campoverde · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · fellowship · Gianni Bonadonna Breast Cancer Research Fellowship
Body mass index as a modifier of the association between pathogenic germline variants and second primary cancer risk in breast cancer survivors
Ininfom Jackson · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · career development · Young Investigator Award
Epigenetic therapy to enhance antibody-drug conjugate efficacy and increase expression of cell surface targets in biliary tract cancers
Nakul Shah · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · research · AACR Trailblazer Cancer Research Grants for Early-stage Investigators
Dissecting Mechanisms of Therapeutic Resistance and Vulnerabilities in CDKN2A/MTAP-deleted Non-Small Cell Lung Cancer
Natalie Vokes · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2026 · career development · Young Investigator Award
A Phase II Trial of the Bruton Tyrosine Kinase Degrader BGB-16673 in combination with BCL-2 inhibitor Sonrotoclax for patients with treatment-naive chronic lymphocytic leukemia (CLL)
Hannah Goulart · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2026 · career development · Young Investigator Award
Multi-Omic PTEN Assessment to Optimize PI3K/AKT Inhibitor Selection in Advanced Breast Cancer
Alexandra Newman · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2025 · grant · Academic Research
Engineering second generation in vivo chimeric antigen receptor macrophages (CARMs) for glioblastoma therapy
Wen Jiang · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025–2026 · award
Development of a clinical-grade CAMKK2 inhibitor for the treatment of cancer
Daniel Frigo · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2025 · grant · Academic Research
Targeting ineffective erythropoiesis in myelodysplastic syndromes with ringed sideroblasts
Simona Colla · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025 · grant · Academic Research
Dissecting mechanisms of resistance to immune checkpoint blockade in NSCLC through the interplay of molecular and spatial architecture
Natalie Vokes · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2025–2028 · award
Examining the feasibility and impact of a safety net clinic-based Food Farmacy and digital culinary medicine program among cancer survivors.
Margaret Raber · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society